NOV Financials
0K58 Stock | 16.00 0.07 0.44% |
Operating Margin 0.0885 | Profit Margin 0.1205 | Payout Ratio 0.1017 | Return On Equity 0.1769 |
NOV | Select Account or Indicator |
Understanding current and past NOV Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of NOV's financial statements are interrelated, with each one affecting the others. For example, an increase in NOV's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in NOV's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NOV Inc. Check NOV's Beneish M Score to see the likelihood of NOV's management manipulating its earnings.
NOV Stock Summary
NOV competes with Hilton Food, Grieg Seafood, Edita Food, Bell Food, and Telecom Italia. NOV is entity of United Kingdom. It is traded as Stock on LSE exchange.Specialization | Industrials, Commercial & Professional Services |
Instrument | UK Stock View All |
Exchange | London Exchange |
Business Address | 10353 Richmond Avenue, |
Sector | Commercial Services & Supplies |
Industry | Industrials |
Benchmark | Dow Jones Industrial |
Website | www.nov.com |
Phone | 346 223 3000 |
You should never invest in NOV without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of NOV Stock, because this is throwing your money away. Analyzing the key information contained in NOV's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
NOV Key Financial Ratios
There are many critical financial ratios that NOV's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that NOV Inc reports annually and quarterly.Revenue | 7.24 B | |||
Gross Profit | 1.41 B | |||
EBITDA | 716 M | |||
Net Income | 993 M | |||
Total Asset | 10.13 B |
NOV Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 13.1B | 9.9B | 9.6B | 10.1B | 9.1B | 16.7B | |
Other Current Liab | 1.5B | 1.4B | 1.3B | 1.5B | 1.4B | 2.3B | |
Net Debt | (1.2B) | (1.7B) | (1.6B) | (1.1B) | (1.2B) | (1.3B) | |
Retained Earnings | 690M | (1.9B) | (2.1B) | (2.1B) | (1.9B) | (1.8B) | |
Accounts Payable | 715M | 489M | 612M | 906M | 815.4M | 629.5M | |
Cash | 1.2B | 1.7B | 1.6B | 1.1B | 962.1M | 1.6B | |
Other Assets | 67M | 156M | 208M | 232M | 208.8M | 229.5M | |
Net Receivables | 2.5B | 1.9B | 1.8B | 2.4B | 2.2B | 2.8B | |
Good Will | 2.8B | 1.5B | 1.5B | 1.5B | 1.4B | 1.3B | |
Inventory | 2.2B | 1.4B | 1.3B | 1.8B | 1.6B | 2.7B | |
Other Current Assets | 247M | 224M | 198M | 187M | 168.3M | 159.9M | |
Total Liab | 5.3B | 4.7B | 4.5B | 5.0B | 4.5B | 6.1B | |
Total Current Assets | 6.1B | 5.2B | 4.9B | 5.5B | 4.9B | 7.5B | |
Intangible Assets | 852M | 527M | 503M | 490M | 441M | 419.0M | |
Other Liab | 393M | 337M | 292M | 298M | 268.2M | 422.4M | |
Net Tangible Assets | 4.1B | 3.2B | 3.0B | 3.1B | 2.8B | 3.0B | |
Long Term Debt | 2.7B | 2.0B | 1.8B | 1.7B | 1.5B | 1.8B |
NOV Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Revenue | 8.5B | 6.1B | 5.5B | 7.2B | 6.5B | 8.9B | |
Gross Profit | 845M | 434M | 774M | 1.4B | 1.3B | 1.8B | |
Operating Income | (458M) | (534M) | (134M) | 391M | 351.9M | 681.0M | |
Ebit | (458M) | (534M) | (134M) | 391M | 351.9M | 681.0M | |
Ebitda | 75M | (182M) | 198M | 716M | 644.4M | 1.2B | |
Cost Of Revenue | 7.6B | 5.7B | 4.8B | 5.8B | 5.2B | 7.1B | |
Income Before Tax | (6.5B) | (2.8B) | (230M) | 238M | 214.2M | 224.9M | |
Net Income | (6.1B) | (2.5B) | (250M) | 155M | 139.5M | 146.5M | |
Income Tax Expense | 369M | 242M | 15M | 83M | 74.7M | 71.0M | |
Tax Provision | 63M | (369M) | 45M | 15M | 13.5M | 14.2M | |
Interest Income | 50M | 105M | 337M | 73M | 84.0M | 129.1M |
NOV Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | 104M | 429M | 17M | (480M) | (552M) | (524.4M) | |
Change In Cash | (256M) | 521M | (101M) | (522M) | (600.3M) | (570.3M) | |
Free Cash Flow | 481M | 700M | 90M | (393M) | (353.7M) | (336.0M) | |
Depreciation | 533M | 352M | 332M | 325M | 292.5M | 473.6M | |
Other Non Cash Items | 6.3B | 3.1B | 209M | (659M) | (757.9M) | (720.0M) | |
Dividends Paid | 77M | 19M | 20M | 78M | 70.2M | 66.7M | |
Capital Expenditures | 244M | 233M | 226M | 201M | 214M | 0.0 | |
Net Income | (6.1B) | (2.5B) | (250M) | 155M | 993M | 1.0B | |
End Period Cash Flow | 1.2B | 1.7B | 1.6B | 1.1B | 962.1M | 1.6B | |
Net Borrowings | (8M) | (521M) | (212M) | (149M) | (9.2M) | (9.7M) | |
Change To Netincome | 6.2B | 2.6B | 169M | 100M | 90M | 85.5M |
NOV Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NOV's current stock value. Our valuation model uses many indicators to compare NOV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NOV competition to find correlations between indicators driving NOV's intrinsic value. More Info.NOV Inc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.24 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for NOV Inc is roughly 4.13 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NOV's earnings, one of the primary drivers of an investment's value.NOV Inc Systematic Risk
NOV's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NOV volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on NOV Inc correlated with the market. If Beta is less than 0 NOV generally moves in the opposite direction as compared to the market. If NOV Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NOV Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NOV is generally in the same direction as the market. If Beta > 1 NOV moves generally in the same direction as, but more than the movement of the benchmark.
NOV Inc Total Assets Over Time
NOV December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of NOV help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NOV Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of NOV Inc based on widely used predictive technical indicators. In general, we focus on analyzing NOV Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NOV's daily price indicators and compare them against related drivers.
Information Ratio | (1.35) | |||
Maximum Drawdown | 0.5047 |
Additional Tools for NOV Stock Analysis
When running NOV's price analysis, check to measure NOV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NOV is operating at the current time. Most of NOV's value examination focuses on studying past and present price action to predict the probability of NOV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NOV's price. Additionally, you may evaluate how the addition of NOV to your portfolios can decrease your overall portfolio volatility.